Explore
Support us
MyLSTM
Clinical Diagnostic Parasitology Laboratory
Menu

Dr Michael Abouyannis

Wellcome Academic Clinical Fellow

Michael is a Wellcome Trust academic clinical fellow currently based at the KEMRI-Wellcome Trust Research Programme in Kilifi, Kenya. His PhD is focussed on understanding the epidemiology and pathophysiology of snakebite, and is also preparing for an early phase clinical trial.

Michael studied medicine at the University of Birmingham before being appointed as an Infectious Diseases Academic Foundation Trainee in Liverpool in 2010. After studying for a Diploma in Tropical Medicine and Hygiene, he worked as a medical officer in emergency medicine and obstetrics in KwaZulu-Natal. He then worked as a field doctor for Médecins Sans Frontières in a refugee camp on the Uganda-Sudan border. In 2016, Michael returned to Liverpool and was appointed as a specialist registrar in Infectious Diseases, Tropical Diseases and General Medicine. Previous academic experience includes HIV research at the Infectious Diseases Institute in Kampala, as well as TB and sepsis research in Malawi.

Michael will be based in Kenya until September 2021, before returning to Liverpool to complete his PhD and registrar training.

Research

Through household survey and hospital surveillance the epidemiology of snakebite in Kilifi, Kenya is being assessed.
Detailed analysis of the immune response to envenoming is being conducted in order to identify components of the response which are either protective or harmful.

Preparedness is underway for an early phase clinical in Kilifi, Kenya.

Selected publications

  • Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa
    Abouyannis M, Menten J, Kiragga A, Lynen L, Robertson G, Castelnuovo B, Manabe YC, Reynolds SJ, Roberts L.
    AIDS. 2011;25(13):1627-35.

    Can emergency departments fulfil British Association for Sexual Health and HIV recommendations for 24-hour access to HIV postexposure prophylaxis following sexual exposure?
    Arkell P, Abouyannis M and Manavi K
    Int J STD AIDS. 2012;23(1):75-6.

    Essential therapeutics skills required of junior doctors.
    Baldwin MJ, Abouyannis M, Butt TF.
    Perspect Med Educ. 2012 Dec;1(5-6):225-36.

    Bleeding events and associated factors in a cohort of adult patients taking warfarin in Sarawak, Malaysia.
    Edwards F, Arkell P, Fong, Roberts LM, Gendy D, Wong CS, Ngu JC, Tiong LL, Bibi FM, Lai LY, Ong TK, Abouyannis M.
    J Thromb Thrombolysis. 2014;38(2):226-34.

    Which clinical parameters predict a CSF diagnosis of meningitis in a population with high HIV prevalence?
    Loughborough W, Abouyannis M, Jones L and Garach S.
    South Afr J HIV Med. 2014;15(2):50-54.

    Drug resistance of Mycobacterium tuberculosis in Malawi: a cross- sectional survey.
    Abouyannis M, Dacombe R, Dambe I, Mpunga J, Faragher B, Gausi F, Ndhlovu H, Kachiza C, Suarez P, Mundy C, Banda HT, Nyasulu I, Squire SB.
    Bull World Health Organ. 2014 Nov 1;92(11):798-806.

    Attitudes of Serodiscordant Couples Towards Antiretroviral-Based HIV Prevention Strategies in Kenya: A Qualitative Study.
    Fowler N, Arkell P, Abouyannis M, James C, Roberts L.
    AIDS Patient Care STDS. 2015 Jan;29(1):33-42.

    Population incidence and mortality of sepsis in an urban African setting 2013-2016.
    Lewis JM, Abouyannis M, Katha G, Nyirenda M, Chatsika G, Feasey NA, Rylance J.
    Clin Infect Dis. 2019 Nov. [Epub ahead of print]